Finance

Beta
Lists
539730:BOM
Fredun Pharmaceuticals Ltd
₹2,619.70
+0.16%
(+4.25) 1D
Jun 19, 3:54:46 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539730...
Open
₹2,644.95
High
₹2,670.00
Low
₹2,570.00
Mkt. cap
14.44B
Avg. vol.
16.27K
Volume
8.71K
Dividend
0.03%
Quarterly dividend
₹0.18
Ex-dividend date
Sep 23, 2025
P/E ratio
42.03
52-wk high
₹2,699.00
52-wk low
₹791.00
EPS
₹62.33
Shares outstanding
3.99M
No. of employees
736
Open
₹2,644.95
High
₹2,670.00
Low
₹2,570.00
Mkt. cap
14.44B
Avg. vol.
16.27K
Volume
8.71K
Dividend
0.03%
Quarterly dividend
₹0.18
Ex-dividend date
Sep 23, 2025
P/E ratio
42.03
52-wk high
₹2,699.00
52-wk low
₹791.00
EPS
₹62.33
Shares outstanding
3.99M
No. of employees
736
News stories
From sources across the web
About Fredun Pharmaceuticals Ltd
CEO-
Employees736
Founded1987
Headquarters-
SectorPharmaceutical industry
Websitefredungroup.com
Last report
May 25, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
2.13B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.19B
1.44B
1.60B
2.13B
Cost of goods sold
880.59M
1.09B
1.15B
1.60B
Cost of revenue
880.59M
1.09B
1.15B
1.60B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
76.34M
82.99M
81.46M
484.22M
Operating expense
162.24M
163.40M
210.93M
270.90M
Total operating expenses
1.04B
1.25B
1.36B
1.87B
Operating income
151.20M
187.30M
235.55M
252.32M
Other non operating income
4.52M
17.06M
9.97M
-49.65M
EBT including unusual items
90.40M
127.05M
140.02M
112.48M
EBT excluding unusual items
90.40M
127.05M
140.02M
112.48M
Income tax expense
22.75M
32.74M
35.24M
53.02M
Effective tax rate
25.16%
25.77%
25.17%
47.14%
Other operating expenses
71.71M
61.48M
111.63M
-244.82M
Net income
67.66M
94.32M
104.78M
59.45M
Net profit margin
5.67%
6.57%
6.55%
2.80%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
6.60M
Interest expense
-65.32M
-77.31M
-105.50M
-126.75M
Net interest expenses
-65.32M
-77.31M
-105.50M
-120.15M
Depreciation and amortization charges
14.19M
18.93M
17.84M
31.50M
EBITDA
163.80M
203.86M
247.83M
272.79M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer